Immune response to the hepatitis B antigen in the RTS,S/AS01 malaria vaccine, and co-administration with pneumococcal conjugate and rotavirus vaccines in African children: A randomized controlled trial

Immune response to the hepatitis B antigen in the RTS,S/AS01 malaria vaccine, and co-administration with pneumococcal conjugate and rotavirus vaccines in African children: A randomized controlled trial

The RTS,S/AS01 malaria vaccine (Mosquirix) reduces the incidence of Plasmodium falciparum malaria and is intended for routine administration to infants in Sub-Saharan Africa. We evaluated the immunogenicity and safety of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate...

Full description

Bibliographic Details
Main Authors: Innocent Valéa, Samuel Adjei, Effua Usuf, Ousmane Traore, Daniel Ansong, Halidou Tinto, Harry Owusu Boateng, Amanda Leach, Athanase Mwinessobaonfou Some, Patrick Buabeng, Johan Vekemans, Louis Arnaud Nana, Amos Kotey, Pascale Vandoolaeghe, Florence Ouedraogo, David Sambian, Marc Lievens, Marc Christian Tahita, Theresa Rettig, Erik Jongert, Palpouguini Lompo, Ali Idriss, Dorota Borys, Sayouba Ouedraogo, Frank Prempeh, Md Ahsan Habib, Lode Schuerman, Hermann Sorgho, Tsiri Agbenyega
Format: Article
Language:English
Published: Taylor & Francis Group 2018-06-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
co-administration
hepatitis b
immunogenicity
malaria
plasmodium falciparum
pneumococcal conjugate vaccine
rts,s
vaccine
Online Access:http://dx.doi.org/10.1080/21645515.2018.1442996

Internet

http://dx.doi.org/10.1080/21645515.2018.1442996

Similar Items